Watch For Semglee to Be "Interchangeable" With Lantus
Semglee (insulin glargine-yfgn U-100) will be the first "interchangeable" biosimilar.
It was originally approved as a new brand of insulin glargine, not a Lantus generic...and switching required a new Rx.
Now Semglee is both biosimilar to, and interchangeable with, Lantus. Biosimilars have to show similar safety, purity, and potency as the original, or "reference," biologic.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote